Risk of secondary cancers from scattered radiation during intensity-modulated radiotherapies for hepatocellular carcinoma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Dong Wook | - |
dc.contributor.author | Chung, Kwangzoo | - |
dc.contributor.author | Chung, Weon Kuu | - |
dc.contributor.author | Bae, Sun Hyun | - |
dc.contributor.author | Shin, Dong Oh | - |
dc.contributor.author | Hong, Seongeon | - |
dc.contributor.author | Park, Sung Ho | - |
dc.contributor.author | Park, Sung-Yong | - |
dc.contributor.author | Hong, Chae-Seon | - |
dc.contributor.author | Lim, Young Kyung | - |
dc.contributor.author | Shin, Dongho | - |
dc.contributor.author | Lee, Se Byeong | - |
dc.contributor.author | Lee, Hyun-ho | - |
dc.contributor.author | Sung, Jiwon | - |
dc.contributor.author | Yoon, Myonggeun | - |
dc.date.accessioned | 2021-09-05T08:54:31Z | - |
dc.date.available | 2021-09-05T08:54:31Z | - |
dc.date.created | 2021-06-15 | - |
dc.date.issued | 2014-05-08 | - |
dc.identifier.issn | 1748-717X | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/98528 | - |
dc.description.abstract | Purpose: To evaluate and compare the risks of secondary cancers from therapeutic doses received by patients with hepatocellular carcinoma (HCC) during intensity-modulated radiotherapy (IMRT), volumetric arc therapy (VMAT), and tomotherapy (TOMO). Methods: Treatments for five patients with hepatocellular carcinoma (HCC) were planned using IMRT, VMAT, and TOMO. Based on the Biological Effects of Ionizing Radiation VII method, the excess relative risk (ERR), excess absolute risk (EAR), and lifetime attributable risk (LAR) were evaluated from therapeutic doses, which were measured using radiophotoluminescence glass dosimeters (RPLGDs) for each organ inside a humanoid phantom. Results: The average organ equivalent doses (OEDs) of 5 patients were measured as 0.23, 1.18, 0.91, 0.95, 0.97, 0.24, and 0.20 Gy for the thyroid, lung, stomach, liver, small intestine, prostate (or ovary), and rectum, respectively. From the OED measurements, LAR incidence were calculated as 83, 46, 22, 30, 2 and 6 per 104 person for the lung, stomach, normal liver, small intestine, prostate (or ovary), and rectum. Conclusions: We estimated the secondary cancer risks at various organs for patients with HCC who received different treatment modalities. We found that HCC treatment is associated with a high secondary cancer risk in the lung and stomach. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | BIOMED CENTRAL LTD | - |
dc.subject | OUT-OF-FIELD | - |
dc.subject | PHOTON DOSE CALCULATION | - |
dc.subject | LARGE TARGET VOLUMES | - |
dc.subject | GLASS ROD DETECTOR | - |
dc.subject | HELICAL TOMOTHERAPY | - |
dc.subject | ARC THERAPY | - |
dc.subject | ETHANOL INJECTION | - |
dc.subject | IMRT | - |
dc.subject | ALGORITHM | - |
dc.subject | PROTON | - |
dc.title | Risk of secondary cancers from scattered radiation during intensity-modulated radiotherapies for hepatocellular carcinoma | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Yoon, Myonggeun | - |
dc.identifier.doi | 10.1186/1748-717X-9-109 | - |
dc.identifier.scopusid | 2-s2.0-84901246509 | - |
dc.identifier.wosid | 000336932800001 | - |
dc.identifier.bibliographicCitation | RADIATION ONCOLOGY, v.9 | - |
dc.relation.isPartOf | RADIATION ONCOLOGY | - |
dc.citation.title | RADIATION ONCOLOGY | - |
dc.citation.volume | 9 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.subject.keywordPlus | OUT-OF-FIELD | - |
dc.subject.keywordPlus | PHOTON DOSE CALCULATION | - |
dc.subject.keywordPlus | LARGE TARGET VOLUMES | - |
dc.subject.keywordPlus | GLASS ROD DETECTOR | - |
dc.subject.keywordPlus | HELICAL TOMOTHERAPY | - |
dc.subject.keywordPlus | ARC THERAPY | - |
dc.subject.keywordPlus | ETHANOL INJECTION | - |
dc.subject.keywordPlus | IMRT | - |
dc.subject.keywordPlus | ALGORITHM | - |
dc.subject.keywordPlus | PROTON | - |
dc.subject.keywordAuthor | HCC | - |
dc.subject.keywordAuthor | IMRT | - |
dc.subject.keywordAuthor | VMAT | - |
dc.subject.keywordAuthor | Tomotherapy | - |
dc.subject.keywordAuthor | Radiophotoluminescence | - |
dc.subject.keywordAuthor | OED | - |
dc.subject.keywordAuthor | EAR | - |
dc.subject.keywordAuthor | ERR | - |
dc.subject.keywordAuthor | LAR | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.